Influence of an abnormal ankle-brachial index on ischemic and bleeding events in patients undergoing percutaneous coronary intervention

Abstract

Background/Aims: Bleeding events after percutaneous coronary intervention (PCI) have important prognostic implications. Data on the influence of an abnormal ankle-brachial index (ABI) on both ischemic and bleeding events in patients undergoing PCI are limited.Methods: We included patients who underwent PCI with available ABI data (abnormal ABI, ≤ 0.9 or > 1.4). The primary endpoint was the composite of all-cause death, myocardial infarction (MI), stroke, and major bleeding.Results: Among 4,747 patients, an abnormal ABI was observed in 610 patients (12.9%). During follow-up (median, 31 months), the 5-year cumulative incidence of adverse clinical events was higher in the abnormal ABI group than in the normal ABI group: primary endpoint (36.0% vs. 14.5%, log-rank test, <i>p</i> < 0.001); all-cause death (19.4% vs. 5.1%, log-rank test, <i>p</i> < 0.001); MI (6.3% vs. 4.1%, log-rank test, <i>p</i> = 0.013); stroke (6.2% vs. 2.7%, log-rank test, <i>p</i> = 0.001); and major bleeding (8.9% vs. 3.7%, log-rank test, <i>p</i> < 0.001). An abnormal ABI was an independent risk factor for all-cause death (hazard ratio [HR], 3.05; <i>p</i> < 0.001), stroke (HR, 1.79; <i>p</i> = 0.042), and major bleeding (HR, 1.61; <i>p</i> = 0.034).Conclusions: An abnormal ABI is a risk factor for both ischemic and bleeding events after PCI. Our study findings may be helpful in determining the optimal method for secondary prevention after PCI.